3159 related articles for article (PubMed ID: 19664631)
1. Early Helicobacter pylori eradication decreases risk of gastric cancer in patients with peptic ulcer disease.
Wu CY; Kuo KN; Wu MS; Chen YJ; Wang CB; Lin JT
Gastroenterology; 2009 Nov; 137(5):1641-8.e1-2. PubMed ID: 19664631
[TBL] [Abstract][Full Text] [Related]
2. Effect of Helicobacter pylori eradication therapy on risk of hospitalization for a major ulcer event.
Hsiao FY; Tsai YW; Wen YW; Kuo KN; Tsai CR; Huang WF
Pharmacotherapy; 2011 Mar; 31(3):239-47. PubMed ID: 21361733
[TBL] [Abstract][Full Text] [Related]
3. A nationwide population-based cohort study shows reduced hospitalization for peptic ulcer disease associated with H pylori eradication and proton pump inhibitor use.
Wu CY; Wu CH; Wu MS; Wang CB; Cheng JS; Kuo KN; Lin JT
Clin Gastroenterol Hepatol; 2009 Apr; 7(4):427-31. PubMed ID: 19264578
[TBL] [Abstract][Full Text] [Related]
4. Highly significant change of the clinical course of relapsing and complicated peptic ulcer disease after cure of Helicobacter pylori infection.
Labenz J; Börsch G
Am J Gastroenterol; 1994 Oct; 89(10):1785-8. PubMed ID: 7942667
[TBL] [Abstract][Full Text] [Related]
5. The effect of eradicating helicobacter pylori on the development of gastric cancer in patients with peptic ulcer disease.
Take S; Mizuno M; Ishiki K; Nagahara Y; Yoshida T; Yokota K; Oguma K; Okada H; Shiratori Y
Am J Gastroenterol; 2005 May; 100(5):1037-42. PubMed ID: 15842576
[TBL] [Abstract][Full Text] [Related]
6. Long-term results of anti-Helicobacter pylori therapy in early-stage gastric high-grade transformed MALT lymphoma.
Chen LT; Lin JT; Tai JJ; Chen GH; Yeh HZ; Yang SS; Wang HP; Kuo SH; Sheu BS; Jan CM; Wang WM; Wang TE; Wu CW; Chen CL; Su IJ; Whang-Peng J; Cheng AL
J Natl Cancer Inst; 2005 Sep; 97(18):1345-53. PubMed ID: 16174856
[TBL] [Abstract][Full Text] [Related]
7. Symptomatic benefit 1-3 years after H. pylori eradication in ulcer patients: impact of gastroesophageal reflux disease.
McColl KE; Dickson A; El-Nujumi A; El-Omar E; Kelman A
Am J Gastroenterol; 2000 Jan; 95(1):101-5. PubMed ID: 10638566
[TBL] [Abstract][Full Text] [Related]
8. High incidence of mortality and recurrent bleeding in patients with Helicobacter pylori-negative idiopathic bleeding ulcers.
Wong GL; Wong VW; Chan Y; Ching JY; Au K; Hui AJ; Lai LH; Chow DK; Siu DK; Lui YN; Wu JC; To KF; Hung LC; Chan HL; Sung JJ; Chan FK
Gastroenterology; 2009 Aug; 137(2):525-31. PubMed ID: 19445937
[TBL] [Abstract][Full Text] [Related]
9. Trends in the prevalence of peptic ulcer disease and Helicobacter pylori infection in family physician-referred uninvestigated dyspeptic patients in Hong Kong.
Xia B; Xia HH; Ma CW; Wong KW; Fung FM; Hui CK; Chan CK; Chan AO; Lai KC; Yuen MF; Wong BC
Aliment Pharmacol Ther; 2005 Aug; 22(3):243-9. PubMed ID: 16091062
[TBL] [Abstract][Full Text] [Related]
10. Effect of Helicobacter pylori eradication and antisecretory maintenance therapy on peptic ulcer recurrence in cirrhotic patients: a prospective, cohort 2-year follow-up study.
Tzathas C; Triantafyllou K; Mallas E; Triantafyllou G; Ladas SD
J Clin Gastroenterol; 2008 Jul; 42(6):744-9. PubMed ID: 18277886
[TBL] [Abstract][Full Text] [Related]
11. Eradication of Helicobacter pylori improves the healing rate and reduces the relapse rate of nonbleeding ulcers in patients with bleeding peptic ulcer.
Arkkila PE; Seppälä K; Kosunen TU; Haapiainen R; Kivilaakso E; Sipponen P; Mäkinen J; Nuutinen H; Rautelin H; Färkkilä MA
Am J Gastroenterol; 2003 Oct; 98(10):2149-56. PubMed ID: 14572560
[TBL] [Abstract][Full Text] [Related]
12. Eradication of Helicobacter pylori does not reduce the incidence of gastroduodenal ulcers in patients on long-term NSAID treatment: double-blind, randomized, placebo-controlled trial.
de Leest HT; Steen KS; Lems WF; Bijlsma JW; van de Laar MA; Huisman AM; Vonkeman HE; Houben HH; Kadir SW; Kostense PJ; van Tulder MW; Kuipers EJ; Boers M; Dijkmans BA
Helicobacter; 2007 Oct; 12(5):477-85. PubMed ID: 17760715
[TBL] [Abstract][Full Text] [Related]
13. Eradication rates of helicobacter pylori infection with second-line treatment: non-ulcer dyspepsia compared to peptic ulcer disease.
Chung SJ; Lee DH; Kim N; Jung SH; Kim JW; Hwang JH; Park YS; Lee KH; Jung HC; Song IS
Hepatogastroenterology; 2007 Jun; 54(76):1293-6. PubMed ID: 17629092
[TBL] [Abstract][Full Text] [Related]
14. The influence of the eradication of Helicobacter pylori on gastric ghrelin, appetite, and body mass index in patients with peptic ulcer disease.
Jang EJ; Park SW; Park JS; Park SJ; Hahm KB; Paik SY; Sin MK; Lee ES; Oh SW; Park CY; Baik HW
J Gastroenterol Hepatol; 2008 Dec; 23 Suppl 2():S278-85. PubMed ID: 19120912
[TBL] [Abstract][Full Text] [Related]
15. Usefulness of proton pump inhibitor (PPI) maintenance therapy for patients with H. pylori-negative recurrent peptic ulcer after eradication therapy for H. pylori: pathophysiological characteristics of H. pylori-negative recurrent ulcer scars and beyond acid suppression by PPI.
Ohara T; Morishita T; Suzuki H; Masaoka T; Ishii H
Hepatogastroenterology; 2004; 51(56):338-42. PubMed ID: 15086153
[TBL] [Abstract][Full Text] [Related]
16. The risk of stomach cancer in patients with gastric or duodenal ulcer disease.
Hansson LE; Nyrén O; Hsing AW; Bergström R; Josefsson S; Chow WH; Fraumeni JF; Adami HO
N Engl J Med; 1996 Jul; 335(4):242-9. PubMed ID: 8657240
[TBL] [Abstract][Full Text] [Related]
17. [National surveillance of Helicobacter pylori eradication in Denmark. Results based on registration of 34.582 drug prescriptions].
Juul KV; Thomsen OO; Nissen A; Hallas J; Kolmos HJ; Funch-Jensen PM; Lauritsen K
Ugeskr Laeger; 1999 Nov; 161(48):6635-8. PubMed ID: 10643349
[TBL] [Abstract][Full Text] [Related]
18. Eradicating Helicobacter pylori in peptic ulcer disease reduces medical costs in the community.
Sone Y; Kumada T; Toyoda H; Yokoyama M; Kato M; Asaka M
Helicobacter; 2008 Oct; 13(5):346-51. PubMed ID: 19250509
[TBL] [Abstract][Full Text] [Related]
19. Eradication rate of Helicobacter pylori in a Mexican population at high risk for gastric cancer and use of serology to assess cure.
Mohar A; Ley C; Guarner J; Herrera-Goepfert R; Figueroa LS; Halperin D; Parsonnet J
Am J Gastroenterol; 2002 Oct; 97(10):2530-5. PubMed ID: 12385434
[TBL] [Abstract][Full Text] [Related]
20. Implications of corpus gastritis, atrophy and cyclooxygenase in the development of gastric erosions after curing Helicobacter pylori infection.
Miyake K; Tatsuguchi A; Suzuki K; Ueki N; Shinji Y; Kusunoki M; Iizumi T; Hiratsuka T; Nishigaki H; Futagami S; Wada K; Tsukui T; Sakamoto C
Dig Liver Dis; 2005 Jun; 37(6):394-401. PubMed ID: 15893277
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
